News EU probes Aspen price gouging allegations Aspen pulled drugs from some countries that rejected price hikes, says EU.
Events Partner Content Joint 23rd Medicines for Europe – 20th IGBA Annual Conferenc... The Joint 23rd Medicines for Europe – 20th IGBA Annual Conference will unite over 300 experts from the generic and biosimilar sectors to discuss market trends, innovative comm
News GSK to search for blockbusters under new CEO Walmsley Big projects are priority as threat from generic Advair looms.
News Mylan recalls pricey US EpiPens, but cheaper version unaffec... More trouble for embattled Mylan.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.